Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

real-world study

This page shows the latest real-world study news and features for those working in and with pharma, biotech and healthcare.

J&J’s Invokana aces diabetic kidney disease trial, setting up filings

J&J’s Invokana aces diabetic kidney disease trial, setting up filings

Johnson &Johnson’s SGLT2 inhibitor Invokana worked so well in a trial involving diabetics with chronic kidney disease that the study has been halted early – potentially opening up a lucrative new ... dapagliflozin). Since then J&J has been trying to

Latest news

  • J&J says real-world data finds no amputation risk for Invokana J&J says real-world data finds no amputation risk for Invokana

    The study depicts how patients are faring on these drugs in the real-world, according to investigator John Buse of the University of North Carolina School of Medicine, who said the ... AZ is still waiting for data read-outs from its cardiovascular

  • Real-world data finds patients feel better on Entresto, says Novartis Real-world data finds patients feel better on Entresto, says Novartis

    Real-world data finds patients feel better on Entresto, says Novartis. Patients on Entresto reported an “early, statistically significant improvement in health status”. ... The real-world data - reported at the European Society of Cardiology Heart

  • Amgen signs real world study and mobile data partnership Amgen signs real world study and mobile data partnership

    Amgen signs real world study and mobile data partnership. Will work with health and wellbeing group Humana on risk prevention. ... Initially targeting multiple conditions, including cardiovascular disease, osteoporosis, neurologic disorders, inflammatory

  • AZ data suggest SGLT2 inhibitors can reduce heart failure risk AZ data suggest SGLT2 inhibitors can reduce heart failure risk

    AZ data suggest SGLT2 inhibitors can reduce heart failure risk. Publishes real-world data for study involving Forxiga/Farxiga, Invokana and Jardiance. ... Now, AZ's study suggests that benefit is reproduced in a generalised, real-world setting and that

  • Sobi looks to real-world trial to push Elocta take-up Sobi looks to real-world trial to push Elocta take-up

    The first patients have been enrolled in a real-world study of Sobi's haemophilia A therapy Elocta aimed at showing its benefits to "physicians, patients and reimbursement authorities". ... dose, he noted, adding "A-SURE is an important study that aims

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • The gold standard of scientific evidence The gold standard of scientific evidence

    However, randomisation can be incorporated into real-world study designs. For instance, pragmatic trial designs blend randomisation with real-world treatment practices. ... For starters, researchers should make available study protocols for all research

  • Pulling together Pulling together

    The real world and data. One aspect of the UK that both the government and industry are keen to talk up is its health service and the opportunity of working with ... Launched in 2012 it was the first time a large, prospective real-world study was

  • Interview: Deepak Khanna, ABPI Interview: Deepak Khanna, ABPI

    Referencing a 'real-world' study into GlaxoSmithKline's (GSK) Relovair in Salford, he says: “ We have a good example where the NHS partnered with three companies to focus on COPD.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Webinar: Demand assessment - Reflecting real world choices

    Webinar: Demand assessment - Reflecting real world choices. How study design which reflects doctors’ real world choices can optimise results. ... study design which reflects doctors’ real world choices can optimise results.

  • The heart of the matter: Part One

    A real-world study can show for one country or local area what happens with a programme and compare it to what happens in another country or area without that programme. ... How can real world evidence be used to explore the gap and measure the impact of

  • The heart of the matter: Part One

    A real-world study can show for one country or local area what happens with a programme and compare it to what happens in another country or area without that programme. ... How can real world evidence be used to explore the gap and measure the impact of

  • Research Partnership

    Therapy Watch recently presented “ real-world” patient data on treatment duration and persistence among European PsO patients. ... How study design which reflects doctors’ real world choices can optimise results.

  • Research Partnership

    Therapy Watch recently presented “ real-world” patient data on treatment duration and persistence among European PsO patients. ... How study design which reflects doctors’ real world choices can optimise results.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Quick links

Infographics

Multimedia